{"id":"W1911381531","doi":"10.1111/apt.13432","title":"Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Cilag; Alnylam Pharmaceuticals; Gilead Sciences; Janssen Research and Development; Innogenetics; Novartis; MedImmune; Roche; AbbVie; Merck; Bristol-Myers Squibb","keywords":"Medicine; Dosing; Placebo; Internal medicine; Gastroenterology; Chronic hepatitis; RNA; microRNA; Immunology; Pharmacology; Virus; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007322361,0.0005483193,0.0004818949,0.0003458378,0.00009356837,0.00004446995,0.0004601406,0.0004467997,0.0000216292],"category_scores_gemma":[0.00002171902,0.0006242637,0.0001264223,0.0004110972,0.0002042611,0.00004545275,0.00024526,0.0004200244,0.00004025128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008976549,"about_ca_system_score_gemma":0.0004415612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002947,"about_ca_topic_score_gemma":0.00206616,"domain_scores_codex":[0.9961095,0.0008391332,0.000891758,0.0009234343,0.0002784465,0.0009577336],"domain_scores_gemma":[0.9985586,0.0002240022,0.0004304867,0.0004261779,0.0001241948,0.0002365057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002752469,0.0009098048,0.1492023,0.00003434564,0.0006302998,0.00003868559,0.0009774044,0.0007096195,0.8454401,5.559473e-7,0.0009339162,0.0008476926],"study_design_scores_gemma":[0.01832687,0.0005721581,0.05236104,0.0001211029,0.0004559492,0.00001581613,0.0002850319,0.001040344,0.9141015,0.00002835208,0.01245018,0.0002416792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946589,0.002820997,0.0000217737,0.000142433,0.0005500041,0.001194845,0.0002173267,0.00003337542,0.0003603408],"genre_scores_gemma":[0.994912,0.0002860322,0.0007723596,0.002588587,0.0002804662,0.00008533207,0.0006568372,0.000118886,0.0002995087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09684129,"threshold_uncertainty_score":0.9996209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02910347638518196,"score_gpt":0.3047417585793402,"score_spread":0.2756382821941583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}